logo
I found a bacteria-eating virus in my loo - could it save your life?

I found a bacteria-eating virus in my loo - could it save your life?

Yahoo28-06-2025
I'm on the hunt for a microbial saviour – a type of virus that can treat infections rather than cause them.
We all know the viral bad guys – Covid, flu, norovirus, herpes, chicken pox, measles… the list goes on.
But there's a type of virus that's not interested in infiltrating our bodies, instead it preys on bacteria.
They're known as bacteria eaters, or bacteriophage, or commonly as phage.
Capturing them could give us new ways of treating infections, including superbugs that are becoming incurable.
So, how to catch a killer?
I've been promised it's surprisingly easy. The team at the Phage Collection Project sent me some vials to collect samples, along with a pair of gloves. All I need to do is hunt for some dirty water, the dirtier the better, dip the vials in and screw on the lid.
I tried a couple of ponds, the juice from a worm-composting bin and then I needed my dirtiest sample. I didn't flush the toilet after a poo and left it for a couple of hours. I pop on a glove and hold my breath as I go in for the final sample. Strict hygiene instructions, including vigorous hand-washing, were followed, at all times.
The vials were packaged up for collection and then three days later I headed off to the University of Southampton to see what was inside.
"They were a bit dirty when I received them," phage scientist Michelle Lin tells me as we don our blue lab-coats and matching gloves to go into the Containment Level 2 microbiology laboratory.
We grab my samples from the fridge, which look much clearer now they have been filtered of any… debris. "It's fine, it's needed," Michelle, who had the unpleasant job, reassures me.
Filtering is the first step in looking for phage, next they get served dinner – a cocktail of yummy bacteria - to help them grow in number.
Now comes the really cool bit – finding a useful phage. The scientists have been working with the local hospital to collect bacteria from patients with troublesome infections.
Michelle grabs a petri dish that's growing bacteria from a patient with a painful, urinary tract infection that keeps coming back.
And to my amazement – one of the phage I collected from my toilet was able to kill this infection in the lab.
"The way to see that the phage has infected bacteria is you get these zones where the bacteria are not growing and that's because they've been killed by the phage," says Michelle.
You can see the leopard print pattern in the petri dish where the phage have been making light work of a bacterial infection that modern medicine was struggling to shift.
"As crazy as it sounds, well done to the toilet sample," says Michelle with great delight.
And when I was offered the chance to name the phage, well of course it's the Gallagher-phage.
"Sounds amazing to me," says Michelle.
So far this is all good fun in the laboratory, but could my phage ever be given to a patient?
"Yes and I hope so," says associate professor Dr Franklin Nobrega as we look at images of my phage captured with an electron microscope.
"Your phage, already in just 24 hours, we were able to get in a high concentration and able to be a very good killer, which means this is very promising for patients, so thank you," said Dr Nobrega.
Phage remind me of a moon lander – a big capsule on spindly legs – just instead of landing on the surface of the moon they use their legs to select their victim.
They then hijack the bacteria and transform it into a mass-production factory for more phage, which burst out of their host, killing it in the process.
There are pros and cons to phage. They reproduce as they go along so you don't need constant doses like you would with drugs.
They are also very picky eaters. You need a precise match between phage and the strain of bacteria you're trying to treat whereas antibiotics tend to kill everything good and bad. So it is harder to find the right phage, but if you do it comes with fewer side effects.
Dr Nobrega tells me infected wounds are a "very good application" for phage because you can apply them directly to the injury, but they can also be inhaled via a nebuliser to treat lung infections or to target urinary tract infections "which is our target currently".
Phage science may sound new and exciting, but it is actually a century old idea stemming from the discoveries of Felix d'Hérelle and Frederick Twort in the 1910s.
Bacteriophage therapy was a branch of medicine and the idea was compelling. Even as late as the 1940s there was an active pharmaceutical industry in western countries trying to produce phage-therapy to defeat bacterial infections.
However, it was rapidly eclipsed by the wonder-drug of the 20th century.
"Antibiotics were working so well that most people said 'why bother'," says Dr Nobrega.
Work on phage therapy continued in places like Georgia and there are individual accounts of it working wonders; but there hasn't been the same depth of medical research and clinical trials as there have for drugs.
But just as the initial success of antibiotics suppressed phage research, the failure of antibiotics is reigniting excitement at their potential.
More than a million people a year are already dying from infections caused by microbes that are resistant to treatment – it's known as the "silent pandemic". By 2050, that figure is projected to reach 10 million a year.
This "antibiotic apocalypse" would mean common infections could kill again and undermine modern medicine. The drugs are also used to make organ transplants, open surgery and chemotherapy possible.
"The predictions around antibiotic resistance are very frightening, but the reality is we're seeing it now and it's only going to get worse," says Prof Paul Elkington, the director of the institute for medical innovation at the University of Southampton.
He is also a doctor with a speciality in lung medicine and is already at the point where - after a year of treatment and turning to ever more toxic and less effective antibiotics - "in the end you have to have a conversation [and say] 'we can't treat this infection, we're really sorry'".
He says we can't rely solely on antibiotics in the future and phage are a potential alternative.
But he warns the steps needed to get from the laboratory and into patients are "uncharted".
Things are changing. Phage therapy is available in the UK on compassionate grounds when other treatments have failed. And the drugs regulator – The Medicines and Healthcare products Regulatory Agency – has published its first official rules to support the development of phage therapy.
"If one looks 15-20 years into the future, with the emerging methodologies, it's going to be possible for them to be much more widely available and for doctors to prescribe phage instead of antibiotics for some infections," says Prof Elkington.
If you want to see if you can find a friendly virus too then The Phage Collection Project are launching their new sampling kits at the Summer Science Exhibition taking place this week at the Royal Society and through their website.
"Antimicrobial resistance is something that could affect all of us," says Esme Brinsden from the Phage Collection Project, "when the public get involved they may just find the next phage that can help treat and save a patient's life".
Photography by the BBC's Emma Lynch
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

They Might Be Making the Perfect ‘Star Trek: Voyager' Game
They Might Be Making the Perfect ‘Star Trek: Voyager' Game

Gizmodo

timean hour ago

  • Gizmodo

They Might Be Making the Perfect ‘Star Trek: Voyager' Game

For as long as Star Trek: Voyager has been around, there has been as much debate about if Captain Janeway made the right decisions navigating her crew's journey home across years of travel from an unexplored corner of the galaxy with little to no support from Starfleet. Should she have killed Tuvix to save the lives of two crewmembers? Should she have been hyperevolved into an amphibian and had sex with one of her senior, also-currently-a-hyperevolved-amphibian officers? Should she have deleted that wife? Well, there's good news. You might soon be able to make those kinds of decisions in the Voyager captain's chair yourself. Announced today at Gamescom in Cologne, Germany, by publisher Daedalic Entertainment, Star Trek: Voyager – Across the Unknown will cast players in the role of the titular ship's captain after it is shunted 70,000 light-years from the Alpha Quadrant and into the unexplored Delta Quadrant. A 'story-driven survival game,' Across the Unknown will see players have to balance repairing the ship after its bumpy journey to the Delta Quadrant, acquiring and maintaining resources, and going on away missions as you and your crew explore the Delta Quadrant and chart a voyage home. Aside from letting players rebuild Voyager's internal systems and research ways to adapt Delta Quadrant technology to sustain its journey and manage crew morale (including even using Borg technology, should you dare), Across the Unknown will have players making key decisions inspired by Voyager's TV adventures, engaging in ship combat and team management for away missions and ship duties, and rogue-like elements to see how long or how far you can take Voyager as her captain. Star Trek has often been a franchise that struggles to adapt to the world of video gaming, in spite of the long and rich video gaming legacy that it has fostered regardless of that struggle. But even in an early glimpse, the potential of Across the Unknown seems to be incredible. This is a pitch-perfect way to take a beloved Star Trek premise (one that the show itself often strained to really match thanks to its approach to episodic storytelling) and marry it with video game mechanics that have you engaging with the things that make Star Trek what it is in the first place: tough decisions and systems management that will only occasionally result in a phasering or two. Or more, if you want it to. You'll be able to out-Janeway Janeway herself when Star Trek: Voyager – Across the Unknown comes to PC in the future. The game is available to wishlist on Steam now, but currently has no release date. Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what's next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who.

Stone Age People Brutalized Their Prisoners of War, New Evidence Suggests
Stone Age People Brutalized Their Prisoners of War, New Evidence Suggests

Gizmodo

time3 hours ago

  • Gizmodo

Stone Age People Brutalized Their Prisoners of War, New Evidence Suggests

When we think of Stone Age people, most imagine small communities living in caves, cutting into their most recent hunt with primitive tools, and imitating their environment with illustrative rock art. People during the Neolithic, however—the last stage of the Stone Age (around 9000 to 3300 BCE)—also waged wars and absolutely demolished their enemies. In a study published today in the journal Science Advances, researchers present horrific evidence suggesting that Neolithic people in northeastern France mutilated foreign invaders. Their findings might represent some of the earliest known indications of gruesome victory celebrations related to war. The international team of researchers analyzed skeletal remains and severed limbs from burial pits dating to between 4300 and 4150 BCE at two sites near Strasbourg, Achenheim and Bergheim. 'A total of 82 humans are analyzed,' they wrote in the study. Their analysis revealed 'differences between victims and nonvictims and suggest that the former were members of invading groups brutally killed, perhaps exposed and deposited in pits—together with trophies in the form of severed upper limbs—by local groups in what might be one of the earliest well-documented instances of martial victory celebrations in prehistoric Europe,' they explained. Previous research in the Upper Rhine Valley had already shown that this time period was marked by military invasions and cultural upheaval, but scientists didn't know whether the human remains at Achenheim and Bergheim were of locals or foreigners and/or prisoners of war. In addition to the severed upper limbs, the researchers also identified injuries such as skull fractures that had not healed. The team, including Valladolid University's Teresa Fernandez-Crespo, suggests these victims met violent ends during war. The individuals without these sorts of unhealed injuries, on the other hand, likely received a regular burial. To investigate the differences between those who were brutally killed and those who weren't, Fernandez-Crespo and her colleagues conducted isotopic analyses. By identifying ratios of isotopes—variants of the same element—in the remains, they discovered that, while the non-victims were locals, the victims of war violence came from other regions. According to the researchers, this indicates that the victims were likely invaders killed by locals. 'In view of their demise, it is probable that the identities of these victims can be attributed to socially remote, nonlocal enemies that became trophies or captives during battles or raids and that may have been considered by their captors as not properly 'human' and hence warranting such treatment,' the researchers explained. For once, the term 'overkill' applies literally.

Help! My Patient Asked Me About Their Smartwatch HRV Status!
Help! My Patient Asked Me About Their Smartwatch HRV Status!

Medscape

time4 hours ago

  • Medscape

Help! My Patient Asked Me About Their Smartwatch HRV Status!

In recent years, smartwatches have gained popularity across Europe, driven by an increase in health awareness, smartphone integration, and advancements in wearable technology. They are now able to monitor an increasing number of health metrics, including the now-popular heart rate variability (HRV). So what happens when a patient comes to the clinic worried about their HRV status, as reported by their watch? To learn more about HRV and its clinical significance, Medscape Medical News spoke with two experts. Professor Thomas Gronwald, PhD, is head of the Department of Performance, Neuroscience, Therapy and Health at MSH Medical School Hamburg, Germany. He is an exercise and training scientist with a focus on internal and external load analysis in strength and conditioning training. Cailbhe Doherty, PhD, is an assistant professor at the School of Public Health, Physiotherapy, and Sports Science at University College Dublin, Ireland. His research is dedicated to investigating the effectiveness of consumer wearables in public health and the integration of mobile technologies in healthcare systems. What is HRV? And is it possible for smartwatches/wearables to accurately measure it? Thomas Gronwald, PhD Doherty: HRV is the variation in time between successive heartbeats. So even if your heart is beating at 60 beats/min, that doesn't mean it's beating exactly once every second. There are tiny fluctuations between beats — sometimes 0.98 seconds, sometimes 1.02 — and that variation is what we call HRV. Those fluctuations aren't random. They're governed by your autonomic nervous system…and within that system, there's a kind of balance: the sympathetic branch, which speeds things up (fight or flight), and the parasympathetic branch, which slows things down (rest and digest). HRV reflects that balance. In simple terms, a higher HRV generally indicates a more adaptable, resilient nervous system, and it's often used as a proxy for recovery, stress, and overall cardiovascular health. Gronwald: The gold standard for a valid and reliable assessment of the time between two successive heartbeats is the electrocardiogram (ECG), which allows recordings in the laboratory or during daily activity — up to 24 hours or longer. Several mobile and user-friendly measurement systems and wearables exist, which can record R-R intervals with different applications and form factors — chest strap systems, adhesive patches, and electrode systems on the skin — that utilize not only electrophysiologic but also optically derived signals such as photoplethysmography…. Most commercially available portable devices show a low absolute error under resting conditions but should always be validated against reference measures to clarify the accuracy of data parameters and maximize real-world application value. Is HRV an important measure of someone's health? Is it an important measure for an athlete? Doherty: Yes, but with some important qualifications. HRV can be a valuable indicator of health, but it's not a silver bullet. In a general health context, higher HRV is often associated with better cardiovascular health, lower levels of chronic stress, and even reduced risk for mortality…. It's a useful window into your overall resilience. The issue is that HRV is highly individual. What's high for one person might be low for another. It's not the kind of measure where a single value tells the whole story. You really need to look at trends over time and ideally interpret them in the context of things like sleep, recovery, illness, and training load. Gronwald: The usefulness of HRV as an indicator of physiologic and pathologic conditions, for risk stratification, and as a marker of autonomic adaptive and regulatory capacity is evident. However, longitudinal data recordings are recommended when trend analysis with contextual data is intended. Considering the mentioned context-sensitive requirements, HRV analysis allows for longitudinal trend analysis of patients and healthy individuals, including athletic and nonathletic populations in various clinical and performance-related settings. This includes the application of HRV monitoring for resting conditions, during and/or after biofeedback and training interventions, as well as general relationships between recovery status, previous exercise conditions, and symptoms of overreaching and overtraining. What should a doctor do if someone goes to them saying their smartwatch is showing that they continuously have a low HRV status? Cailbhe Doherty, PhD Doherty: I'd suggest it should be treated as a starting point. The physician might ask: Has this person noticed other symptoms — fatigue, poor sleep, high stress? Has their resting heart rate changed? Are there lifestyle factors — alcohol, illness, overtraining, or mental health — that could explain the trend? And if it seems warranted, they could conduct more standardized assessments, such as an ECG-based HRV measurement or a broader autonomic function test. The data is not medical grade and we don't know enough about how the proprietary algorithms are processing the signals. But if the question is whether the HRV trend might reflect something real, then yes, it's possible. Ultimately, I think wearables are better at raising questions than answering them. And that's not a bad thing. Is such data reliable? Gronwald: This depends strongly on the wearable or recording device. The measurement principles and the type of analysis and processing of the biosignal vary significantly between different devices. On the one hand, sleep analyses are used during the night, while on the other hand, context-free time points during the day are often used. Here, care should be taken to include standardized situations for a measurement and interpretation context. It is recommended to use validated measurement systems that either use the entire night as a reference phase or a consistent measurement situation early in the morning after waking up without prior stressors. Both approaches have advantages and disadvantages. How can someone improve their HRV? Gronwald: HRV improves when the body is balanced between activity and recovery within hemodynamic boundaries, with strong support from sleep, stress reduction, and a healthy active lifestyle. Regular physical activity, especially moderate aerobic exercise — such as walking, cycling, or swimming — and strength training can increase HRV over time. Breathing exercises with slow, deep, and diaphragmatic breathing — for example 4-6 breaths per minute — can help to activate the parasympathetic nervous system, which improves HRV. Good sleep quality with consistent sleep patterns, enough deep sleep, and avoiding late-night screen time and activity are essential for higher HRV. Further, stress management and practices such as meditation, social connection, mindfulness, or progressive muscle relaxation are linked to emotional well-being and can reduce stress and therefore improve HRV. Finally, healthy nutrition habits such as a balanced diet rich in whole foods, omega-3 fatty acids, fruits, and vegetables supports HRV — including limitation of stimulants, alcohol, nicotine, and processed foods. How important do you think wearable technology is to support the provision of healthcare across Europe? What role do you think it will play in the future? Doherty: Healthcare systems across Europe are facing enormous pressure: aging populations, rising chronic disease, long waiting lists, and constrained resources. Wearables offer something really compelling in that context: the ability to monitor people continuously, passively, and remotely, outside the clinic, in real-world settings. [But] at the moment, most wearable data isn't integrated into the healthcare system. It lives in consumer ecosystems — Apple, Google, Fitbit, Garmin — and that creates problems around standardization, privacy, and clinical utility. We can't expect a GP or a cardiologist to wade through raw data from 10 different apps and figure out what it means. There are also big equity issues. Most wearables are still designed and validated in relatively narrow populations — usually younger, healthier, often White, middle-income users. If we start using wearable data in clinical decision-making, we need to be absolutely sure it's valid across diverse populations, otherwise we risk baking health inequalities into digital health systems. Another issue is data privacy. When we start linking consumer data to clinical records, the stakes get much higher. Who owns the data? Who profits from it? Who gets access to it? Ultimately, I think wearables will play an increasingly important role in population health monitoring, early detection, and personalized prevention. But for that to happen in a way that is safe, effective, and fair, we need interoperability, regulatory oversight — especially on algorithm transparency, robust validation in real-world populations, and a clear framework around data rights and governance. Gronwald and Doherty reported no relevant financial relationships.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store